February 11, 2022
Kyle Sampson discusses the White House Office of Management and Budget review of the U.S. FDA’s draft harmonized Quality System Regulation
November 16, 2020
Kyle Sampson explains why the new U.S. Congress will work quickly to reestablish key provisions of the Affordable Care Act
September 9, 2021
14th Annual King & Spalding Medical Device Summit
March 23, 2021
Kyle Sampson to Speak on 8th Annual Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products Virtual Conference
February 23, 2021
FDA Inspections in 2021 for Drug and Device Manufacturers
November 10, 2020
13th Annual King & Spalding Medical Device Summit
February 7, 2022
A Pandemic Silver Lining: FDA’s New Guidance on Using Digital Health Technologies for Clinical Investigations
December 30, 2021
FDA Issues Draft Guidances on Transitioning Devices from EUAs and Agency Enforcement Policies
August 27, 2021
FDA Rejects Bids To Market CBD-Based Dietary Supplements
August 6, 2021
FDA Finalizes “Intended Use” Regulations